Core Scientific, Inc./tx
CORZZ· Nasdaq
Filed Mar 2, 2026 · 10-K · 61 days after period end · 0001628280-26-013305
derived · Computed from the longer spans the company filed.
| Metric | Q4 2025dderived from reported figures | Q4 2024 | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures |
|---|---|---|---|---|
| Revenue | $79.76M | $94.93M | $141.93M | $121.25M |
| Net Income | $215.96M | -$291.15M | -$195.69M | -$434.85M |
| EPS Diluted | — | -$0.69 |
Core Scientific, Inc./tx · CIK 1839341 · Engraved from SEC EDGAR
| — |
| — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ended Dec 31, 2025 · filed Mar 2, 2026 · 61 d after period end